Bio Solution Co.,Ltd. (KOSDAQ:086820)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,120.00
+100.00 (1.25%)
At close: Jan 19, 2026
-3.14%
Market Cap193.86B
Revenue (ttm)8.27B
Net Income (ttm)-1.28B
Shares Out24.17M
EPS (ttm)-53.69
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume102,447
Average Volume90,747
Open8,100.00
Previous Close8,020.00
Day's Range7,960.00 - 8,250.00
52-Week Range7,050.00 - 13,200.00
Beta0.37
RSI51.94
Earnings DateMar 17, 2026

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 71
Stock Exchange KOSDAQ
Ticker Symbol 086820
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.